ACE and kidney disorder: Neither age, gender, transplantation duration, primary kidney disease, comorbidities (except as mentioned above), smoking history, maintenance immunosuppression nor use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEi/ARBs) was significantly different between the patients reaching primary and secondary outcomes (Tables 1,2,3).